Skip to main content

Table 1 Study population characteristics in terms of knowledge and preferences of GMa

From: Use of generic medicines in Latvia: awareness, opinions and experiences of the population

Sociodemographic characteristics Are informed about GM Are not informed about GM No opinion
From total (n = 1005) 727 (72.3%) 226 (22.5%) 52 (5.2%)
Gender
 Female, n = 528 408 (77.3%) 96 (18.2%) 24 (4.5%)
 Male, n = 477 319 (66.9%) 130 (27.3%) 28 (5.8%)
Age
 18–24, n = 120 71 (59.2%) 42 (35.0%) 7 (5.8%)
 25–34, n = 207 155 (74.9%) 47 (22.7%) 5 (2.4%)
 35–44, n = 188 141 (75.0%) 39 (20.7%) 8 (4.3%)
 45–54, n = 192 130 (67.7%) 50 (26.0%) 12 (6.3%)
  > 55, n = 298 229 (76.9%) 49 (16.4%) 20 (6.7%)
Education
 Primary, n = 24 14 (58.3%) 10 (41.7%) 0
 Secondary, n = 339 235 (69.3%) 85 (25.1%) 19 (5.6%)
 Higher, n = 642 478 (74.5%) 131 (20.4%) 33 (5.1%)
Sociodemographic characteristics Would prefer/rather prefer GM Would prefer/rather prefer brand-name medicine No difference/do not have an opinion
From total (n = 1005) 211 (21.0%) 287 (28.6%) 507 (50.4%)
Age
 18–24, n = 120 24 (20.2%) 24 (19.3%) 72 (60.5%)
 25–34, n = 207 43 (20.8%) 47 (22.7%) 117 (56.5%)
 35–44, n = 188 47 (25.0%) 41 (21.8%) 100 (53.2%)
 45–54, n = 192 50 (26.0%) 55 (28.6%) 87 (45.3%)
  > 55, n = 298 47 (15.7%) 121 (40.5%) 130 (43.8%)
Nationality
 Latvian, n = 586 107 (18.3%) 174 (29.7%) 305 (52.0%)
 Other, n = 419 104 (24.8%) 113 (27.0%) 202 (50.4%)
  1. aBolded text refers to responses that differ significantly from the total (adjusted standardized residuals value > 1.96 or < − 1.96)